Padagis Enhances Naloxone HCl Nasal Spray with Extended Shelf-Life
The recent extension of the shelf-life for Naloxone HCl Nasal Spray, now set at 36 months, marks a significant advancement in the fight against opioid overdoses. This extension allows communities and first responders improved access to this important life-saving medication during the ongoing opioid epidemic.
Padagis, a leading generic manufacturer, has made this extended shelf life for its over-the-counter (OTC) Naloxone HCl Nasal Spray 4 mg, ensuring that individuals have ready access to necessary medication in emergencies. Naloxone is a critical tool used to reverse the effects of an opioid overdose, and its availability can make the difference between life and death.
With an unwavering commitment to healthcare accessibility, Padagis is dedicated to lowering healthcare expenses while ensuring high-quality medicines. "Every person deserves affordable access to medications that address their critical needs, especially in the face of the opioid crisis," expressed Pamela Hoffman, President of Padagis.
Affordable and Accessible Options for Consumers
The affordability factor is crucial, with Padagis’ Naloxone nasal spray available at just $29.99 for a two-dose pack, making it one of the most cost-effective options on the market. This accessibility is only enhanced by the new shelf-life extension, offering even greater value for those who need it most.
As the company prepares to roll out this newly manufactured medicine shortly, it emphasizes the importance of adhering to the expiration dates indicated on product packaging. This guidance helps ensure safety and effectiveness for the end-users.
Commitment to Addressing the Opioid Crisis
Padagis has ramped up its commitment to providing Naloxone to combat the opioid crisis. As recent trends suggest a decline in opioid overdose deaths, Padagis believes that its efforts are contributing positively. The company’s lingering aim is to expand the availability of Naloxone to both consumers and healthcare providers.
The recent changes are part of Padagis’ larger mission to eliminate barriers to life-saving medications, ensuring that those who might be at risk have access to critical care. By maximizing the shelf-life, the company supports enhanced access in communities that require it most.
About Padagis
Based in Allegan, Michigan, Padagis is focused on improving patient and consumer health through high-quality, affordable healthcare products. This pharmaceutical company is a key player in the market of extended topical medications and specialty drugs within the United States and Israel. Its flagship product, Naloxone, is intended to save lives by reversing opioid overdoses. Padagis employs a dedicated team of over 1,300 professionals worldwide, all working towards alleviating the opioid crisis and ensuring that essential medications remain accessible.
Frequently Asked Questions
What is Naloxone used for?
Naloxone is used to rapidly reverse the effects of an opioid overdose, potentially saving a person's life during such emergencies.
How long is the new shelf-life for Padagis’ Naloxone?
The new shelf-life has been extended to 36 months, allowing for increased accessibility and readiness in emergency situations.
What is the price of Padagis’ Naloxone nasal spray?
The price for a two-dose pack of Padagis’ Naloxone nasal spray is set at $29.99, making it an affordable option for consumers.
Why is the extension of shelf-life significant?
Extending the shelf-life is significant as it ensures that medication remains effective for longer periods, thus increasing accessibility for those in need.
Where can consumers learn more about Padagis?
Consumers can learn more about Padagis and its products by visiting their official website, which offers detailed information about their offerings and objectives.
